ABSTRACT
Objective and Design: The treatment of recurrent rosacea has always been a problem. Oral minocycline has been widely used in the treatment of rosacea. However, the efficacy and safety of ozonated hydrotherapy combined with LED yellow light irradiation and oral minocycline for mild to moderate papulopustular rosacea (PPR) has not been thoroughly studied. Methods: Patients with rosacea who met the criteria and had complete clinical statistic admitted to our hospital from April 2021 to September 2022 were retrospectively collected and divided into combined therapy group and oral only group. The patients in the two groups were treated with minocycline for 8 weeks. In addition, the patients in combined therapy group were treated with ozone hydrotherapy once a week, followed by LED yellow light irradiation for a total of 4 weeks. The Investigator' s global assessment (IGA) score was used to assess the condition. The efficacy was evaluated using the patients' subjective symptom scores. Skin lesion images and adverse reactions were recorded. The recurrence rate was observed after 24 weeks of follow-up. Results: A total of 39 patients included in the study. After 4 weeks of treatment, the effective rate was 90% in combined therapy group and 52.63% in oral only group (p<0.05). After 8 weeks of treatment, the total score of the patients' subjective symptom scores and the scores of itching and burning sensation in combined therapy group were lower than those in oral only group (p<0.05). After 24 weeks of follow-up, the recurrence rate of combined therapy group was 5%, and that of oral only group was 26.32%. The mild adverse reactions experienced by both groups disappeared during follow-up. Conclusion: This combination therapy has a significant, rapid and safe therapeutic effect, especially in relieving itching and burning sensations, and may reduce the recurrence rate.
ABSTRACT
Background: Acne is a chronic inflammatory disease of the pilosebaceous unit. Improper treatment of acne can lead to skin lesions in some people. Acne hypertrophic scar is relatively rare, but it significantly affects the appearance and beauty, and usually has a great psychological and social impact on patients. Objective: To evaluate the clinical efficacy and safety of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) combined with 5-fluorouracil (5-FU) injection and triamcinolone acetonide (TAC) solution in the treatment of acne hypertrophic scars. Methods: This article included 13 outpatients with acne accompanied by acne hypertrophic scar who were treated from September 2018 to September 2022. All patients received ALA-PDT combined with intralesional injection of 5-FU and TAC. At first, patients received ALA-PDT once every two weeks. After the third ALA-PDT, 5-FU and TAC were mixed in a ratio of 3:7, and then immediately injected in the local scars. The effect was observed after 1 month. If the effect is not obvious, a further injection of 5-FU and TAC to the lesion is necessary. The patients were followed up for 6 months. The Vancouver Scars Scale (VSS) was used to evaluate the efficacy before and after treatment and photos of patients were collected. Results: After ALA-PDT combined with intralesional 5-FU and TAC, all patients achieved good clinical efficacy. 23.08% of patients received one local injection and 76.92% received two local injections. After treatment, the scar lesions were reduced and flattened, and the scars became soft. The total score of VSS after treatment was significantly lower than before, and the difference was statistically significant (P<0.05). The main adverse reactions were pain, erythema, and pigmentation, which can subside within 3 weeks. There was no recurrence after 6 months of follow-up. Conclusion: ALA-PDT combined with intralesional injection of 5-FU and TAC significantly affects acne hypertrophic scars, which is worthy of further in-depth and large-scale research.
ABSTRACT
In this work, we used photodynamic therapy(ALA-PDT) to treat 2 patients with perianal hemorrhoids combined with condyloma acuminatum. After 4 photodynamic treatments, the condyloma acuminata skin lesions completely disappeared. At the same time, we unexpectedly found that the patient's hemorrhoids skin lesions had mostly faded, and did not reappear during the half-year follow-up. Photodynamic therapy is satisfactory in the treatment of hemorrhoids combined with condyloma acuminatum, and the recurrence rate is low. We also have found that photodynamic therapy is equally effective on hemorrhoid skin lesions. PDT may be adopted as a new strategy in the study and treatment of hemorrhoids. To the best of our knowledge, no such cases have been reported.
Subject(s)
Condylomata Acuminata , Hemorrhoids , Photochemotherapy , Condylomata Acuminata/drug therapy , Hemorrhoids/complications , Hemorrhoids/drug therapy , Humans , Photochemotherapy/methods , Photosensitizing Agents/therapeutic useABSTRACT
Dynamical tunable plasmon-induced transparency (PIT) possesses the unique characteristics of controlling light propagation states, which promises numerous potential applications in efficient optical signal processing chips and nonlinear optical devices. However, previously reported configurations are sensitive to polarization and can merely operate under specific single polarization. In this work we propose an anisotropic PIT metamaterial device based on a graphene-black phosphorus (G-BP) heterostructure to realize a dual-polarization tunable PIT effect. The destructive interference coupling between the bright mode and dark modes under the orthogonal polarization state pronounced anisotropic PIT phenomenon. The coupling strength of the PIT system can be modulated by dynamically manipulating the Fermi energy of the graphene via the external electric field voltage. Moreover, the three-level plasmonic system and the coupled oscillator model are employed to explain the underlying mechanism of the PIT effect, and the analytical results show good consistency with the numerical calculations. Compared to the single-polarization PIT devices, the proposed device offers additional degrees of freedom in realizing universal tunable functionalities, which could significantly promote the development of next-generation integrated optical processing chips, optical modulation and slow light devices.
ABSTRACT
BACKGROUND: In China, photodynamic therapy(PDT) has been widely accepted in the treatment of acne. However, there are few studies on PDT combined with isotretinoin of moderate to severe acne. AIMS: To evaluate the efficacy and safety of PDT combined with isotretinoin in the treatment of moderate to severe acne. METHODS: 70 cases of moderate and severe acne patients were randomly divided into PDT group and combination group. In combination group, patients were treated with PDT, once/2weeks, for 3 times; and oral isotretinoin, 10 mg twice a day for 3 months. The PDT group was treated with PDT alone. The skin lesions were counted before treatment and in the 4th, 6th, 8th, and 12th weeks to evaluate the clinical efficacy. Adverse reactions during the treatment were recorded. We monitored the liver function of the combination group once a month. The recurrence rate was recorded 6 months after treatment. RESULTS: A total of 67 patients completed the study. The effective rates of combination group in the 4th, 6th, 8th, and 12th weeks of treatment were 28.6 %, 71.4 %, 91.4 %, and 94.1 %, respectively; the effective rates of PDT group in the 4th, 6th, 8th, and 12th weeks of treatment were 22.9 %, 54.3 %, 74.3 %, and 78.8 %, respectively; the effective rates of two groups were statistically significant in the 6th, 8th, and 12th weeks of treatment (P < 0.05). There was no significant difference in pain score between two groups during the photodynamic therapy(Pï¼0.05). Adverse reactions, such as erythema and pustule during photodynamic therapy in both groups were tolerable. The pigmentation subsided in about 3 months. The recurrence rate of combination group was significantly lower than that of PDT group(7% VS 24 %,Pï¼0.05). CONCLUSION: PDT combined with isotretinoin has higher effective rate and lower recurrence rate than single PDT, and is a choice for the treatment of moderate to severe acne.
Subject(s)
Acne Vulgaris , Photochemotherapy , Acne Vulgaris/drug therapy , Aminolevulinic Acid/therapeutic use , China , Humans , Isotretinoin/therapeutic use , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Treatment OutcomeABSTRACT
This study aims to explore the key and differentially expressed long non-coding RNAs (lncRNAs) and elucidates their possible mechanisms in malignant-transformed Human bronchial epithelial (BEAS-2B) cells induced by coal tar pitch extracts (CTPE). BEAS-2B cells were stimulated with 2.4 µg/ml CTPE, then passaged for three times which were named CTPE1 and then passaged until passage 30 (CTPE30). The results showed that cells of CTPE30 appeared abnormal morphology. Furthermore, migration, clonality and proliferation of cells in CTPE group were significantly increased compared with those in control groups. However, the apoptosis of cells in CTPE group was inhibited. A total of 569 differentially expressed mRNAs and 707 differentially expressed lncRNAs were screened out, among which four lncRNAs were validated and were consistent with the microarray results. 32 target genes were screened out by Co-expression network. The study suggests that differentially expressed lncRNAs may play a potential role in lung carcinogenesis.
Subject(s)
Cell Transformation, Neoplastic/genetics , Coal Tar/toxicity , RNA, Long Noncoding , Apoptosis/drug effects , Cell Line , Cell Proliferation/drug effects , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Humans , Microarray Analysis , RNA, Messenger , Wound Healing/drug effectsABSTRACT
As a human carcinogen, coal tar pitch (CTP) can significantly increase the risk of lung cancer. However, the mechanism underlying CTP-induced lung carcinogenesis has not been well understood. This study aims to explore the role of the LncRNA-ENST00000501520 in the proliferation of malignant-transformed human bronchial epithelial cells (BAES-2B) induced by CTP extract for the first time. BEAS-2B cells were stimulated with 2.4 µg/mL CTP extract, and then passaged for three times, which were named passage 1 and then passaged until passage 30 (named as CTP group). The ENST000001520 of cells in CTP group was interfered using siRNA. The results showed that ENST000001520 located in cell nucleus (>80%) had no or weak ability of protein encoding. After interference of ENST000001520, the migration and proliferation of cells in CTP group were inhibited, and the cell cycle was arrested in the G0/G1 phase; however, the apoptosis of cells in CTP group was promoted. The target genes (SKB1, CLTB, TAP2, PIPK2, and SOCS3) of ENST000001520 were screened out, and the mRNA and protein expression of SBK1 and SOCS3 was significantly decreased after ENST000001520 interference. SBK1 and SOCS3 may play a promoting role in occurrence and development of cancers. The study suggests that LncRNA-ENST00000501520 could promote the proliferation in malignant-transformed BEAS-2B cells induced with CTP extract which may be mediated by target genes. This study may provide a new target for prevention and treatment of lung cancer.
Subject(s)
Bronchi/drug effects , Cell Proliferation , Cell Transformation, Neoplastic/drug effects , Cell Transformation, Neoplastic/genetics , Coal Tar/toxicity , RNA, Long Noncoding/physiology , Respiratory Mucosa/drug effects , Bronchi/metabolism , Bronchi/pathology , Carcinogenesis/drug effects , Carcinogenesis/genetics , Carcinogenesis/metabolism , Cell Line , Cell Proliferation/drug effects , Cell Proliferation/genetics , Cell Transformation, Neoplastic/pathology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Gene Expression Regulation, Neoplastic , Humans , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Respiratory Mucosa/metabolismABSTRACT
Energetic ionic salts (EISs) are attracting extensive attention because of their ready preparation and some excellent properties and performances that are comparable to those of common explosives with neutral molecules. Hydroxylamine (HA) is protonated or ionized as H-HA+ and preferred to be introduced into EISs to form HA-based EISs with almost all kinds of anions since these EISs possess higher packing densities and thus more excellent detonation performances than others with the same anions. Moreover, relative to that of pure HA, the thermal stability of HA-based EISs is significantly enhanced. This significantly enhanced thermal stability can extend the application of HA via deprotonation of H-HA+ back to HA; however, the mechanism for stabilization of HA by salification remains unclear. Herein, we employed thermodynamic and kinetic calculations and molecular dynamics simulations to reveal the thermal stability mechanisms of many currently synthesized HA-based EISs and some previously reported EISs with inorganic anions as well as those of pure HA and its aqueous solution. As a result, we have found that the enhanced stability of HA-based EISs is mainly due to the ionization and separation of HA molecules themselves. That is, H-HA+, as an ionized product, is more molecularly stable than HA, with significantly strengthened covalent bonds. The separation of H-HA+ ions or HA molecules makes decomposition more difficult as decomposition initiation varies from bimolecular to unimolecular reactions of HA, with a significant increase in the energy barrier. We have, therefore, proposed a strategy for the stabilization of unstable systems, such as neutral N-rich energetic compounds, by ionization and separation to strengthen these systems and change the decomposition mechanism by increasing the energy barriers of trigger steps such that these barriers become more difficult to overcome, respectively.
ABSTRACT
Psoriasis is a common chronic dermatosis characterized by keratinocyte hyperproliferation accompanied by inflammatory reactions. Pathological changes upset the balance between keratinocyte proliferation, differentiation, and death in psoriatic lesions, suggesting that molecules with topical anti-inflammatory, anti-proliferation and anti-angiogenesis abilities may be useful for its treatment. The flavonoid astilbin is the major active component extracted from the rhizome of Smilax glabra, which has been widely used in China to treat inflammatory and autoimmune diseases. Here, we investigate the potential of astilbin as a treatment for psoriasis. We reveal that astilbin inhibits the growth of HaCaT keratinocytes. Detailed study shows that astilbin leads to S phase arrest of the cell cycle by induction of p53 and p21 and activated-AMPK. Additionally, astilbin induced keratinocyte differentiation correlated with suppression of keratin 5 (KRT5) and KRT14 proteins (the markers of epidermal basal layer) and induction KRT1 and KRT10 proteins (occurring in the upper layers). Moreover, astilbin regulates the expression of VEGF in human HaCaT keratinocytes. These results suggest that astilbin may be a promising agent for psoriasis treatment.
Subject(s)
Cell Differentiation/drug effects , Cell Proliferation/drug effects , Flavonols/pharmacology , Keratinocytes/drug effects , Anti-Inflammatory Agents/pharmacology , Cell Line , China , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Humans , Inflammation/drug therapy , Inflammation/metabolism , Keratinocytes/metabolism , Keratins/metabolism , Psoriasis/drug therapy , Psoriasis/metabolism , Rhizome/chemistry , S Phase/drug effects , Tumor Suppressor Protein p53/metabolismABSTRACT
Nucleotide binding oligomerization domain (NOD)-like receptors (NLRs) are a class of cytoplasmic pattern-recognition receptors with a major role in innate immunity. Fourteen of the twenty-two human NLRs contain a pyrin domain and form the NLRP subfamily (NLRPs). Among NLRPs, NLRP2 is less well-understood in aspects of distribution and functions, especially in central nervous system (CNS). This study was the first to explore the expression of NLRP2 in central nervous system both under normal conditions and in ischemic stroke models. We found NLRP2 protein had a basal level of expression in CNS, mainly in astrocytes and was significantly elevated in ischemic brains in vivo or oxygen-glucose deprivation-treated cells in vitro. And silencing of NLRP2 genes could reduce the apoptotic rate of oxygen-glucose deprivation-treated cells. Thus high expression of NLRP2, especially in astrocytes, may play important roles in the pathophysiological process of ischemic stroke and has potential clinical value for the treatment of ischemic stroke.